[Anti-EGFR therapy: towards a "à la carte" targeting of hepatocellular carcinoma]

MeSH terms

• Animals
• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• Carcinoma, Hepatocellular / drug therapy*
• Carcinoma, Hepatocellular / etiology
• Carcinoma, Hepatocellular / physiopathology
• Carcinoma, Hepatocellular / prevention & control
• Cell Line, Tumor
• Cetuximab
• Clinical Trials, Phase II as Topic
• Disease Models, Animal
• Epidermal Growth Factor / physiology
• ErbB Receptors / antagonists & inhibitors*
• ErbB Receptors / physiology
• Erlotinib Hydrochloride
• Gefitinib
• Humans
• Ligands
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / etiology
• Liver Neoplasms / physiopathology
• Liver Neoplasms / prevention & control
• Multicenter Studies as Topic
• Neoplasm Recurrence, Local / prevention & control
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / therapeutic use*
• Quinazolines / administration & dosage
• Quinazolines / therapeutic use*
• Rats
• Signal Transduction
• Transforming Growth Factor alpha / physiology